Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
12.39
-0.16 (-1.27%)
At close: Sep 4, 2026, 4:00 PM EDT
12.38
-0.01 (-0.08%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of $434.48 million as of September 4, 2026. Its market cap has increased by 76.19% in one year.
Market Cap
434.48M
Enterprise Value
393.23M
1-Year Change
76.19%
Ranking
Category
Stock Price
$12.39
ChartMarket Cap Chart
Since December 31, 2004, Fennec Pharmaceuticals's market cap has increased from $65.80M to $434.48M, an increase of 560.31%. That is a compound annual growth rate of 9.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 434.50M | 100.69% |
| Dec 31, 2025 | 216.50M | 24.86% |
| Dec 31, 2024 | 173.40M | -41.97% |
| Dec 29, 2023 | 298.80M | 18.62% |
| Dec 30, 2022 | 251.90M | 120.19% |
| Dec 31, 2021 | 114.40M | -40.51% |
| Dec 31, 2020 | 192.30M | 48.95% |
| Dec 31, 2019 | 129.10M | 2.54% |
| Dec 31, 2018 | 125.90M | -20.82% |
| Dec 29, 2017 | 159.00M | 444.52% |
| Dec 30, 2016 | 29.20M | 53.68% |
| Dec 31, 2015 | 19.00M | -28.30% |
| Dec 31, 2014 | 26.50M | 208.14% |
| Dec 31, 2013 | 8.60M | -34.35% |
| Dec 31, 2012 | 13.10M | 61.73% |
| Dec 30, 2011 | 8.10M | -55.98% |
| Dec 31, 2010 | 18.40M | 260.78% |
| Dec 31, 2009 | 5.10M | - |
| Dec 31, 2008 | 5.10M | -85.26% |
| Dec 31, 2007 | 34.60M | 138.62% |
| Dec 29, 2006 | 14.50M | -51.67% |
| Dec 30, 2005 | 30.00M | -54.41% |
| Dec 31, 2004 | 65.80M | - |
| Dec 31, 2004 | 65.80M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 460.11M |
| Inhibikase Therapeutics | 458.83M |
| Ocugen | 457.80M |
| Vogenx | 447.45M |
| Arcturus Therapeutics Holdings | 442.26M |
| Galectin Therapeutics | 438.70M |
| Evommune | 435.51M |
| Benitec Biopharma | 427.37M |